4579.T
Price:
$1129
Market Cap:
$27.61B
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States and phase I clinical trial in China, as well as in phase I clinical trial in China and the United States to treat cancer. The company also provides veterinary products such as, grapiprant for osteoarthritis in dogs; ghrelin receptor agonist to treat cancer-related anorexia/cachexia syndrome, and constipation resulting from spinal cord injury; and ELURA, a drug f...[Read more]
Industry
Biotechnology
IPO Date
2011-07-20
Stock Exchange
JPX
Ticker
4579.T
According to RaQualia Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is -9.15%. This represents a change of 319.55% compared to the average of -2.18% of the last 4 quarters.
The mean historical ROE of RaQualia Pharma Inc. over the last ten years is -9.04%. The current -9.15% ROE has changed 1.26% with respect to the historical average. Over the past ten years (40 quarters), 4579.T's ROE was at its highest in in the December 2021 quarter at 12.25%. The ROE was at its lowest in in the September 2015 quarter at -14.17%.
Average
-9.04%
Median
-7.09%
Minimum
-41.08%
Maximum
15.79%
Discovering the peaks and valleys of RaQualia Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.31%
Maximum Annual ROE = 15.79%
Minimum Annual Increase = -13186.67%
Minimum Annual ROE = -41.08%
| Year | ROE | Change |
|---|---|---|
| 2024 | -8.89% | 68.05% |
| 2023 | -5.29% | -140.18% |
| 2022 | 13.16% | -16.63% |
| 2021 | 15.79% | -204.31% |
| 2020 | -15.13% | -13186.67% |
| 2019 | 0.12% | -100.40% |
| 2018 | -28.64% | 2.31% |
| 2017 | -1.19% | -93.81% |
| 2016 | -19.22% | -53.21% |
| 2015 | -41.08% | 201.25% |
The current ROE of RaQualia Pharma Inc. (4579.T) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.34%
5-year avg
-0.07%
10-year avg
-9.04%
RaQualia Pharma Inc.’s ROE is greater than NANO MRNA Co.,Ltd. (-30.79%), greater than MediciNova, Inc. (-23.12%), greater than CellSeed Inc. (-53.29%), greater than Japan Medical Dynamic Marketing, Inc. (-2.67%), less than Kidswell Bio Corporation (23.30%), greater than CanBas Co., Ltd. (-39.13%), greater than Stella Pharma Corporation (-4.41%), less than Techno Medica Co., Ltd. (6.08%), less than Daiken Medical Co., Ltd. (13.89%), greater than Chiome Bioscience Inc. (-62.16%),
| Company | ROE | Market cap |
|---|---|---|
| -30.79% | $10.48B | |
| -23.12% | $11.53B | |
| -53.29% | $9.36B | |
| -2.67% | $12.46B | |
| 23.30% | $10.76B | |
| -39.13% | $15.57B | |
| -4.41% | $8.54B | |
| 6.08% | $14.26B | |
| 13.89% | $12.64B | |
| -62.16% | $7.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RaQualia Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RaQualia Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is RaQualia Pharma Inc.'s ROE?
How is the ROE calculated for RaQualia Pharma Inc. (4579.T)?
What is the highest ROE for RaQualia Pharma Inc. (4579.T)?
What is the 3-year average ROE for RaQualia Pharma Inc. (4579.T)?
What is the 5-year average ROE for RaQualia Pharma Inc. (4579.T)?
How does the current ROE for RaQualia Pharma Inc. (4579.T) compare to its historical average?